Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New diagnostic method in pulmonary carcinoid].

Eszter Csiszér1, Balázs Antus, Gabriella Himber

  • 1Országos Korányi Tbc és Pulmonológiai Intézet, Budapest, Hungary. csiszer@koranyi.hu

Magyar Onkologia
|October 9, 2007
PubMed
Summary

Chromogranin A shows potential as a tumor marker for neuroendocrine malignancies. Elevated Chromogranin A levels indicate carcinoid metastasis, aiding in patient follow-up alongside imaging.

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division Analysis.

Scientific data·2026
Same author

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma.

medRxiv : the preprint server for health sciences·2026
Same author

Efficient and scalable training set generation for automated pollen monitoring with Hirst-type samplers.

Scientific reports·2025
Same author

Clinical Significance of Time-to-Surgery and COVID-19 Pandemic in Surgically Treated Non-Small Cell Lung Cancer.

Thoracic cancer·2025
Same author

Impact of long-term elexacaftor/tezacaftor/ivacaftor therapy on oxidative stress in cystic fibrosis: early insights.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025

Area of Science:

  • Oncology
  • Biochemistry
  • Medical Diagnostics

Context:

  • Tumor markers are crucial in clinical oncology for diagnostics and patient monitoring.
  • Neuroendocrine tumors, like pulmonary carcinoids, often require specific biomarkers.
  • Chromogranin A is recognized as a potential marker for neuroendocrine malignancies.

Purpose:

  • To evaluate the utility of Chromogranin A as a tumor marker in patients with carcinoid tumors.
  • To correlate Chromogranin A serum levels with the stage and presence of metastasis in carcinoid tumors.

Summary:

  • The study measured serum Chromogranin A levels in patients diagnosed with carcinoid tumors.
  • Data indicate that elevated Chromogranin A levels are associated with detectable carcinoid metastasis.

Related Experiment Videos

  • Despite a small patient cohort, findings suggest Chromogranin A's role in detecting metastatic disease.

    • Impact:

    • Chromogranin A may serve as a valuable complementary biomarker in the management of carcinoid tumors.
    • This research supports the use of Chromogranin A in conjunction with imaging for patient follow-up.
    • Further research with larger cohorts could solidify Chromogranin A's role in carcinoid diagnostics and monitoring.